Table 1.
Characteristic | Group 1 [Reactive venting] (n=30) | Group 2 [Immediate venting] (n=33) | p-value |
---|---|---|---|
Age, years | 52 ± 16.5 | 60 ± 11.0 | 0.0255 |
Male sex | 23 (77) | 22 (67) | 0.38 |
Preexisting cardiac disease | |||
Coronary artery disease | 12 (40) | 17 (52) | 0.36 |
Non-ischemic cardiomyopathy | 6 (20) | 7 (21) | 0.905 |
Prior myocardial infarction | 1 (3) | 3 (9) | 0.349 |
Pulmonary arterial hypertension | 6 (20) | 3 (9) | 0.217 |
Systemic hypertension | 17 (57) | 17 (52) | 0.682 |
Other comorbidities | |||
Chronic kidney disease | 6 (20) | 4 (12) | 0.393 |
Diabetes mellitus | 7 (23) | 8 (24) | 0.933 |
Hyperlipidemia | 13 (43) | 13 (39) | 0.751 |
Peripheral arterial disease | 1 (3) | 1 (3) | 0.945 |
Prior CT interventions | |||
Coronary artery bypass grafting | 1 (3) | 3 (9) | 0.349 |
Percutaneous coronary interventions | 4 (13) | 4 (12) | 0.885 |
Valve repair/replacement | 4 (13) | 0 | 0.030 |
Heart transplant | 2 (7) | 1 (3) | 0.498 |
Pre-ECMO pH | 7.19 ± 0.14 | 7.24 ± 0.13 | 0.196 |
Pre-ECMO Lactate | 8.33 ± 6.20 | 6.24 ± 3.91 | 0.133 |
Pre-ECMO serum creatinine | 1.93 ± 1.12 | 1.84 ± 1.24 | 0.763 |
SAVE score | −10.5 (−14 to −5) | −9 (−12 to −5) | 0.366 |
Values presented as number (percentage) or mean ± standard deviation